industry

Amgen’s stock saw a significant increase of over 12% after revealing positive initial data on its innovative weight loss injection, MariTide. This announcement sparked concerns among investors regarding new competition in the rapidly expanding weight loss drug market. The news led to a decline in the stock prices of Novo Nordisk and Eli Lilly, key
0 Comments
Universal’s recent release, “The Fall Guy,” starring Ryan Gosling and Emily Blunt, had a lackluster start at the box office, pulling in $3.15M from early showings and Wednesday advance screenings. The movie is projected to make around $35M-$40M over its opening weekend. This sluggish start can be attributed to delays in the production of feature
0 Comments
The recent news of Tesla’s progress in bringing its advanced driver-assistance feature to China has sparked excitement among investors. However, according to Mark Hawtin, GAM Investment Management’s investment director, the buzz surrounding Tesla’s Full Self Driving (FSD) service may be misleading. Despite the hype, the reality is that Tesla’s FSD does not offer full autonomous
0 Comments
Coinbase, the leading digital token marketplace in the United States, recently released its first-quarter earnings report, exceeding analysts’ expectations. The company reported a revenue of $1.64 billion, surpassing the estimated $1.34 billion. Additionally, Coinbase reported a net income of $1.18 billion, equivalent to $4.40 per share. These figures mark a significant improvement compared to the
0 Comments
In the realm of blockbuster movies, the importance of a theatrical release cannot be overstated. Despite the rise of streaming platforms and the convenience they offer, studios have come to realize that there is nothing more profitable than a traditional theatrical release and the downstream revenue streams that follow. This realization has been especially prominent
0 Comments
In a time where studios were experimenting with different release strategies due to the Covid-19 pandemic, Universal took a gamble on Christopher Nolan’s World War II-set film, Oppenheimer. Despite initial skepticism about the movie’s potential, Universal decided to invest $100 million in the production. The decision to open Oppenheimer in theaters rather than opt for
0 Comments
In a surprising move just prior to releasing their first-quarter earnings report, Google announced that it would be letting go of about 200 employees from its “Core” teams. This reorganization will involve transferring some roles to India and Mexico, a decision that has raised eyebrows within the tech industry. The Core unit is crucial for
0 Comments
Hotel giant Marriott International (NASDAQ:MAR) has recently increased its annual adjusted profit forecast following a mixed performance in the first quarter. Despite weakening trends in North America, Marriott is relying on the surge in international travel demand to drive its full-year profit. The company anticipates a significant boost in revenue per available room (RevPAR) from
0 Comments
Australia’s major banks are anticipated to report weaker first-half profits as operating costs remain high and competition for mortgage and deposit sales intensifies. This has led to a reduction in margins, putting a strain on overall profitability. Although historically, rising interest rates have been beneficial for the Big Four banks, the current scenario has forced
0 Comments
Following the news of CEO Elon Musk’s decision to cut jobs in Tesla’s Supercharger team, the company’s shares plummeted nearly 6% on Tuesday, closing at $183.28. This drop marked a 26% decrease for the year, signaling investor concerns about the company’s future direction and financial stability. According to reports, Musk informed managers at Tesla about
0 Comments
Amazon.com recently reported quarterly results that surpassed Wall Street’s expectations. The company’s focus on artificial intelligence has been a significant factor in driving growth in its cloud-computing division. Despite the impressive performance, Amazon’s current-quarter revenue forecast fell short of expectations, causing a slight dip in the stock price during the regular session. Chief Financial Officer
0 Comments
The Federal Trade Commission has taken a bold step in challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs. These companies, including Novo Nordisk, AstraZeneca, Boehringer Ingelheim, and others, have been warned about improperly listed drug patents, particularly for medications related to Type 2 diabetes, asthma, and COPD. The practice
0 Comments